Stem Cell Therapy for Vascular Disease

Trends in Cardiovascular Medicine

Volumn 17, Issue 7, 2007, Pages 246-251

  Adams, Benjamin ^a   Xiao, Qingzhong ^a   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ANGIOGENESIS; ANGIOPLASTY; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL DIVISION; CELL THERAPY; EMBRYONIC STEM CELL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULAR DISEASE;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; STEM CELLS;

EID: 34948842403     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.08.005     Document Type: Review

References (43)

1. Aicher A., Rentsch M., Sasaki K., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 100 (2007) 581-589
2. Anversa P., Leri A., Rota M., et al. Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25 (2007) 589-601
3. Assmus B., Walter D.H., Lehmann R., et al. Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J 27 (2006) 2989-2995
4. Campbell G.R., and Campbell J.H. Development of tissue engineered vascular grafts. Curr Pharm Biotechnol 8 (2007) 43-50
5. Gray B.H., and Sullivan T. The treatment of iliac artery atherosclerosis with angioplasty and intravascular stents. Vasc Med 1 (1996) 287-291
6. Hoenig M.R., Campbell G.R., Rolfe B.E., and Campbell J.H. Tissue-engineered blood vessels: alternative to autologous grafts?. Arterioscler Thromb Vasc Biol 25 (2005) 1128-1134
7. Hu Y., Davison F., Ludewig B., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106 (2002) 1834-1839
8. Hu Y., Davison F., Zhang Z., and Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108 (2003) 3122-3127
9. Hu Y., Zhang Z., Torsney E., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in apoE-deficient mice. J Clin Invest 113 (2004) 1258-1265
10. Illi B., Scopece A., Nanni S., et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 96 (2005) 501-508
11. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
12. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
13. Kang H.J., Lee H.Y., Na S.H., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 (2006) I145-I151
14. Katz J.N., Turer A.T., and Becker R.C. Cardiology and the critical care crisis: a perspective. J Am Coll Cardiol 49 (2007) 1279-1282
15. Kong D., Melo L.G., Gnecchi M., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
16. Kuntz R.E. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 99 (1999) 847-851
17. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99 (2002) 4391-4396
18. L'Heureux N., Paquet S., Labbe R., et al. A completely biological tissue-engineered human blood vessel. FASEB J 12 (1998) 47-56
19. L'Heureux N., Dusserre N., Marini A., et al. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4 (2007) 389-395
20. Lin Y., Chen X., Yan Z., et al. Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 291 (2006) 1-10
21. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
22. Margariti A., Zeng L., and Xu Q. Stem cells, vascular smooth muscle cells and atherosclerosis. Histol Histopathol 21 (2006) 979-985
23. Mayr M., Li C., Zou Y., et al. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 14 (2000) 261-270
24. Mayr U., Zou Y., Zhang Z., et al. Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair. Circ Res 98 (2006) 412-420
25. Menendez P., Bueno C., Wang L., and Bhatia M. Human embryonic stem cells: potential tool for achieving immunotolerance?. Stem Cell Rev 1 (2005) 151-158
26. Osterziel K.J. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. Eur Heart J 28 (2007) 638
27. Planat-Benard V., Silvestre J.S., Cousin B., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 (2004) 656-663
28. Prunet-Marcassus B., Cousin B., Caton D., et al. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 312 (2006) 727-736
29. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
30. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
31. Seeger F.H., Zeiher A.M., and Dimmeler S. Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S110-S113
32. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 (2004) 318-322
33. Wang H., Riha G.M., Yan S., et al. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol 25 (2005) 1817-1823
34. Wang X.X., Zhang F.R., Shang Y.P., et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 49 (2007) 1566-1571
35. Wassmann S., Werner N., Czech T., and Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99 (2006) e74-e83
36. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
37. + progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol 26 (2006) 2244-2251
38. + progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am J Physiol Cell Physiol 292 (2007) C342-C352
39. Xu Q. The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 3 (2006) 94-101
40. Xu Q., Zhang Z., Davison F., and Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in apoE-deficient mice. Circ Res 93 (2003) e76-e86
41. Yamashita J., Itoh H., Hirashima M., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 (2000) 92-96
42. Yoshioka T., Takahashi M., Shiba Y., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70 (2006) 61-69
43. Zeng L., Xiao Q., Margariti A., et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol 174 (2006) 1059-1069